Pneumococcal Disease Risk and Vaccination in Cardiac Conditions: Indian Cardiologists' Group Recommendations Dr. Garima Soni29 Sept 2025 12:30 PM ISTIndia: A recent Indian expert consensus highlighted the importance of pneumococcal vaccination for individuals with chronic cardiac conditions who...
Identifying Aspirin Candidates for Primary Prevention: Focus on Men Aged 40- 50 with Metabolic Syndrome and Cardiometabolic Risk Lalhmangaihkimi29 Sept 2025 12:15 PM ISTUnique CV Risk in India- Epidemiological BackdropCardiovascular diseases (CVDs) remain the leading cause of death in India, with a WHO-reported...
Unlocking the Potential of Pharmacists for a Healthier India - Manjiri Gharat Mrs Manjiri Gharat25 Sept 2025 2:45 PM ISTThe International Pharmaceutical Federation (FIP), the global leader in advancing pharmacy, has been championing the pharmacy profession for over a...
India's Growing Footprint in Global Research : Recognition, Reflection and the Road Ahead - Dr (Prof) Raju Vaishya Raju Vaishya22 Sept 2025 4:45 PM ISTThe release of the 2025 "Updated Science-Wide Author Databases of Standardized Citation Indicators" by Prof. John P.A. Ioannidis of Stanford...
Undenatured Collagen in Osteoarthritis Management: Practitioner's Review in 2025 Naresh Pincha22 Sept 2025 11:18 AM ISTOsteoarthritis is the most prevalent musculoskeletal disorder globally and the leading cause of chronic pain and disability. In India, over 62 million...
Evidence-Based Recommendation by Indian Pediatric Experts on the Use of Acid-Reducing Medications in Children Deeksha Bhandari20 Sept 2025 12:26 PM ISTA recent Indian evidence-based review highlighted recommendations from a multidisciplinary team of paediatricians on the appropriate use of ...
Beta-Blockers After MI in Patients with LVEF Above 40%: Findings of BETAMI-DANBLOCK Trial Presented at ESC Congress 2025 Prem Aggarwal18 Sept 2025 11:45 AM ISTBeta-blocker therapy reduced the risk of death or major adverse cardiovascular events by 15% in patients with MI and a LVEF above 40%, a recently...
Beta-blockers Reduce Death, MI, Heart Failure 25% in Mildly Reduced LVEF: Latest Meta-Analysis Presented at ESC Congress 2025 Prem Aggarwal12 Sept 2025 9:00 AM ISTBeta-blocker therapy results in a 25% reduction in the composite outcome of all-cause death, new myocardial infarction, or heart failure in patients...
From Potential to Global Impact: Strengthening India’s Research Ecosystem through Capacity Building - Dr Prashant Mishra Dr Prashant Mishra10 Sept 2025 2:35 PM ISTIndia stands at an exciting crossroads in medical research. We have some of the world’s most talented clinicians, scientists, and healthcare...
Exploring Buccal Prochlorperazine: A Targeted Review of Its Pharmacological Profile Dr. Kamal Kant Kohli9 Sept 2025 12:15 PM ISTThe Clinical Value of Buccal ProchlorperazineProchlorperazine remains a clinically valuable agent for managing nausea, dizziness, vertigo, and...
Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study Deeksha Bhandari8 Sept 2025 12:00 PM ISTA real-world Indian study found that glipizide, alone or with metformin, improves glycemic control in patients with declining renal function without...
Overcoming Antifungal Resistance: The Case for Selenium Sulfide Dr. Kamal Kant Kohli5 Sept 2025 12:30 PM ISTThe rising incidence of fungal infections and increasing resistance to antifungal treatments present significant global health challenges, accompanied...
